MedTrace Logo

Hemostatic Forceps vs. Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers

NCT06393907 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-05-01

No results posted yet for this study

Summary

A randomized controlled trial to evaluate the efficacy of hemostatic forceps and bipolar electrocautery probes in patient with high risk bleeding gastroduodenal ulcers.

Conditions

  • Gastroduodenal Ulcer

Interventions

DEVICE

Hemostatic Forceps

The experimental device will be used for control bleeding in high risk gastroduodenal ulcers.

DEVICE

Bipolar Electrocautery Probes

The active comparator devices will be used for control bleeding in high risk gastroduodenal ulcers.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Uayporn Kaosombatwattana, MD · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-26
Primary Completion
2026-03-26
Completion
2026-04-26
FDA Device
Yes

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06393907 on ClinicalTrials.gov